Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.

Rostam MA, Piva TJ, Rezaei HB, Kamato D, Little PJ, Zheng W, Osman N

Open source

DOI
10.1111/1440-1681.12335
Published
2015 Feb
Container
Clinical and experimental pharmacology & physiology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/1440-1681.12335,
  title = {Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.},
  author = {Rostam MA and Piva TJ and Rezaei HB and Kamato D and Little PJ and Zheng W and Osman N},
  year = {2015},
  journal = {Clinical and experimental pharmacology \& physiology},
  doi = {10.1111/1440-1681.12335},
  url = {https://doi.org/10.1111/1440-1681.12335}
}

RIS

TY  - JOUR
TI  - Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.
AU  - Rostam MA
AU  - Piva TJ
AU  - Rezaei HB
AU  - Kamato D
AU  - Little PJ
AU  - Zheng W
AU  - Osman N
PY  - 2015
JO  - Clinical and experimental pharmacology & physiology
DO  - 10.1111/1440-1681.12335
UR  - https://doi.org/10.1111/1440-1681.12335
ER  - 

APA

MA, R., TJ, P., HB, R., D, K., PJ, L., W, Z., & N, O. (2015). Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.. Clinical and experimental pharmacology & physiology. https://doi.org/10.1111/1440-1681.12335

Source records